The opposing roles of IL-21 and TGFβ1 in chronic inflammatory bowel disease

Biochemical Society Transactions

Volumn 39, Issue 4, 2011, Pages 1061-1066

  MacDonald, Thomas T ^a   Bell, Iona ^a   Monteleone, Giovanni ^b  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

Inflammatory bowel disease (IBD); Interleukin 21 (IL 21); Regulatory T cell (T reg cell); Smad7; Transforming growth factor 1 (TGF 1)

Indexed keywords

ANTI TUMOR NECROSIS FACTOR ALPHA; INTERLEUKIN 21; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR INHIBITOR; UNCLASSIFIED DRUG;

CELL SURVIVAL; CHRONIC INFLAMMATORY BOWEL DISEASE; CONFERENCE PAPER; DISEASE SEVERITY; ENTERITIS; HUMAN; IMMUNE RESPONSE; IMMUNOSUPPRESSIVE TREATMENT; INTESTINE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; TH17 CELL;

ANIMALS; HUMANS; IMMUNITY, INNATE; INFLAMMATORY BOWEL DISEASES; INTERLEUKIN-17; INTERLEUKINS; T-LYMPHOCYTES; TRANSFORMING GROWTH FACTOR BETA1;

EID: 79960888630     PISSN: 03005127     EISSN: 14708752     Source Type: Journal    
DOI: 10.1042/BST0391061     Document Type: Conference Paper

References (47)

1. MacDonald, T.T. (2008) The gut is still the biggest immune organ in the body. Mucosal Immunol. 1, 246-247
2. Xavier, R.J. and Podolsky, D.K. (2007) Unravelling the pathogenesis of inflammatory bowel disease. Nature 448, 427-434 (Pubitemid 47123518)
3. MacDonald, T.T. and Monteleone, G. (2005) Immunity, inflammation and allergy in the gut. Science 307, 1920-1925
4. Sartor, R.B. (2011) Key questions to guide a better understanding of host-commensal microbiota interactions in intestinal inflammation. Mucosal Immunol. 4, 127-132
5. Lees, C.W., Barrett, J.C., Parkes, M. and Satsangi, J. (2011) New IBD genetics: common pathways with other diseases. Gut, doi:10.1136/gut.2009.199679
6. Fusunyan, R.D., Quinn, J.J., Fujimoto, M., MacDermott, R.P. and Sanderson, I.R. (1999) Butyrate switches the pattern of chemokine secretion by intestinal epithelial cells through histone acetylation. Mol. Med. 5, 631-640
7. Neurath, M.F., Weigmann, B., Finotto, S., Glickman, J., Nieuwenhuis, E., Iijima, H., Mizoguchi, A., Mizoguchi, E., Mudter, J., Galle, P.R. et al. (2002) The transcription factor T-bet regulates mucosal T cell activation in experimental colitis and Crohn's disease. J. Exp. Med. 195, 1129-1143
8. Monteleone, G., Biancone, L., Marasco, R., Morrone, G., Marasco, O., Luzza, F. and Pallone, F. (1997) Interleukin 12 is expressed and actively released by Crohn's disease intestinal lamina propria mononuclear cells. Gastroenterology 112, 1169-1178 (Pubitemid 27157528)
9. Heller, F., Florian, P., Bojarski, C., Richter, J., Christ, M., Hillenbrand, B., Mankertz, J., Gitter, A.H., Bürgel, N., Fromm, M. et al. (2005) Interleukin-13 is the key effector Th2 cytokine in ulcerative colitis that affects epithelial tight junctions, apoptosis, and cell restitution. Gastroenterology 129, 550-564 (Pubitemid 41096643)
10. Strober, W., Zhang, F., Kitani, A., Fuss, I. and Fichtner-Feigl, S. (2010) Proinflammatory cytokines underlying the inflammation of Crohn's disease. Curr. Opin. Gastroenterol. 26, 310-317
11. Maynard, C.L. and Weaver, C.T. (2009) Intestinal effector T cells in health and disease. Immunity 31, 389-400
12. Ivanov, I.I. and Littman, D.R. (2010) Segmented filamentous bacteria take the stage. Mucosal Immunol. 3, 209-212
13. Fujino, S., Andoh, A., Bamba, S., Ogawa, A., Hata, K., Araki, Y. and Bamba, T. (2003) Increased expression of interleukin 17 in inflammatory bowel disease. Gut 52, 65-70 (Pubitemid 36020767)
14. Rovedatti, L., Kudo, T., Biancheri, P., Ogawa, A., Hata, K., Araki, Y. and Bamba, T (2009) Differential regulation of interleukin 17 and interferon γ production in inflammatory bowel disease. Gut 58, 1629-1636
15. Brand, S., Beigel, F., Olszak, T., Zitzmann, K., Eichhorst, S.T., Otte, J.M., Diepolder, H., Marquardt, A., Jagla, W., Popp, A. et al. (2006) IL-22 is increased in active Crohn's disease and promotes proinflammatory gene expression and intestinal epithelial cell migration. Am. J. Physiol. Gastrointest. Liver Physiol. 290, 827-838
16. Atreya, R. and Neurath, M.F. (2008) Signaling molecules: the pathogenic role of the IL-6/STAT-3 trans signaling pathway in intestinal inflammation and in colonic cancer. Curr. Drug Targets 9, 369-374 (Pubitemid 352025210)
17. Annunziato, F., Cosmi, L., Santarlasci, V., Maggi, L., Liotta, F., Mazzinghi, B., Parente, E., Filì, L., Ferri, S., Frosali, F. et al. (2007) Phenotypic and functional features of human Th17 cells. J. Exp. Med. 204, 1849-1861
18. O'Connor, Jr, W., Kamanaka, M. and Booth, C.J. (2009) Protective function for interleukin 17A in T cell-mediated intestinal inflammation. Nat. Immunol. 10, 603-609
19. Yang, X.O., Chang, S.H. and Park, H. (2008) Regulation of inflammatory responses by IL-17F. J. Exp. Med. 205, 1063-1075
20. MacDonald, T.T. (2010) Inside the microbial and immune labyrinth: totally gutted. Nat. Med. 16, 1194-1195
21. Mehta, D.S., Wurster, A.L. and Grusby, M.J. (2004) Biology of IL-21 and the IL-21 receptor. Immunol. Rev. 202, 84-95
22. C family cytokines. Nat. Rev. Immunol. 9, 480-490
23. Monteleone, G., Monteleone, I., Fina, D., Vavassori, P., Del Vecchio Blanco, G., Caruso, R., Tersigni, R., Alessandroni, L., Biancone, L., Naccari, G.C. et al. (2005) Interleukin-21 enhances T-helper cell type I signalling and interferon-γ production in Crohn's disease. Gastroenterology 128, 687-694
24. Sarra, M., Monteleone, I., Stolfi, C., Fantini, M.C., Sileri, P., Sica, G., Tersigni, R., Macdonald, T.T., Pallone, F. and Monteleone, G. (2010) Interferon-γ -expressing cells are a major source of interleukin-21 in inflammatory bowel diseases. Inflamm. Bowel Dis. 16, 1332-1339
25. Fina, D., Sarra, M., Fantini, M.C., Rizzo, A., Caruso, R., Caprioli, F., Stolfi, C., Cardolini, I., Dottori, M., Boirivant, M. et al. (2008) Regulation of gut inflammation and Th17 cell response by interleukin-21. Gastroenterology 134, 1038-1048
26. Sengupta, N. and MacDonald, T.T. (2007) The role of matrix metalloproteinases in stromal/epithelial interactions in the gut. Physiology 22, 401-409
27. Monteleone, G., Caruso, R., Fina, D., Peluso, I., Gioia, V., Stolfi, C., Fantini, M.C., Caprioli, F., Tersigni, R., Alessandroni, L. et al. (2006) Control of matrix metalloproteinase production in human intestinal fibroblasts by interleukin 21. Gut 55, 1774-1780 (Pubitemid 44893577)
28. Caruso, R., Fina, D., Peluso, I., Stolfi, C., Fantini, M.C., Gioia, V., Caprioli, F., Del Vecchio Blanco, G., Paoluzi, O.A., Macdonald, T.T. et al. (2007) A functional role for interleukin-21 in promoting the synthesis of the T-cell chemoattractant, MIP-3α, by gut epithelial cells. Gastroenterology 132, 166-175 (Pubitemid 46108732)
29. Izadpanah, A., Dwinell, M.B., Eckmann, L., Varki, N.M. and Kagnoff, M.F. (2001) Regulated MIP-3α/CCL20 production by human intestinal epithelium: mechanism for modulating mucosal immunity. Am. J. Physiol. Gastrointest. Liver Physiol. 280, G710-G719
30. Kwon, J.H., Keates, S., Bassani, L., Mayer, L.F. and Keates, A.C. (2002) Colonic epithelial cells are a major site of macrophage inflammatory protein 3α (MIP-3α) production in normal colon and inflammatory bowel disease. Gut 51, 818-826
31. Katchar, K., Kelly, C.P., Keates, S., O'Brien, M.J. and Keates, A.C. (2007) MIP-3α neutralizing monoclonal antibody protects against TNBS-induced colonic injury and inflammation in mice. Am. J. Physiol. Gastrointest. Liver Physiol. 292, G1263-G1271
32. Sartor, R.B. (2008) Microbial influences in inflammatory bowel diseases. Gastroenterology 134, 577-594
33. Packey, C.D. and Sartor, R.B. (2008) Interplay of commensal and pathogenic bacteria, genetic mutations, and immunoregulatory defects in the pathogenesis of inflammatory bowel diseases. J. Intern. Med. 263, 597-606
34. Miller, A., Lider, O., Roberts, A.B., Sporn, M.B. and Weiner, H.L. (1992) Suppressor T cells generated by oral tolerization to myelin basic protein suppress both in vitro and in vivo immune responses by the release of transforming growth factor β after antigen-specific triggering. Proc. Natl. Acad. Sci. U.S.A. 89, 421-425
35. Monteleone, G., Kumberova, A., Croft, N.M., McKenzie, C., Steer, H.W. and MacDonald, T.T. (2001) Blocking Smad7 restores TGF-β1 signaling in chronic inflammatory bowel disease. J. Clin. Invest. 108, 601-609
36. Monteleone, G., Mann, J., Monteleone, I., Vavassori, P., Bremner, R., Fantini, M., Del Vecchio Blanco, G., Tersigni, R., Alessandroni, L., Mann, D. et al. (2004) A failure of transforming growth factor-β1 negative regulation maintains sustained NF-κB activation in gut inflammation. J. Biol. Chem. 279, 3925-3932
37. Monteleone, G., Del Vecchio Blanco, G., Monteleone, I., Fina, D., Caruso, R., Gioia, V., Ballerini, S., Federici, G., Bernardini, S., Pallone, F. and MacDonald, T.T. (2005) Post-transcriptional regulation of Smad7 in the gut of patients with inflammatory bowel disease. Gastroenterology 129, 1420-1429 (Pubitemid 41597384)
38. Monteleone, G., Boirivant, M., Pallone, F. and MacDonald, T.T. (2008) TGF-β1 and Smad7 in the regulation of IBD. Mucosal Immunol. 1 (Suppl. 1), S50-S53
39. Fantini, M.C., Rizzo, A., Fina, D., Caruso, R., Sarra, M., Stolfi, C., Becker, C., Macdonald, T.T., Pallone, F., Neurath, M.F. and Monteleone, G. (2009) Smad7 controls resistance of colitogenic T cells to regulatory T cell-mediated suppression. Gastroenterology 136, 1308-1316
40. Hovhannisyan, Z., Treatman, J., Littman, D.R. and Mayer, L. (2011) Characterization of interleukin-17-producing regulatory T cells in inflamed intestinal mucosa from patients with inflammatory bowel diseases. Gastroenterology 140, 957-965
41. Ito, R., Kita, M., Shin-Ya, M., Kishida, T., Urano, A., Takada, R., Sakagami, J., Imanishi, J., Iwakura, Y., Okanoue, T. et al. (2008) Involvement of IL-17A in the pathogenesis of DSS-induced colitis in mice. Biochem. Biophys. Res. Commun. 377, 12-16
42. Leppkes, M., Becker, C., Ivanov, I.I., Hirth, S., Wirtz, S., Neufert, C., Pouly, S., Murphy, A.J., Valenzuela, D.M., Yancopoulos, G.D. et al. (2009) RORγ -expressing Th17 cells induce murine chronic intestinal inflammation via redundant effects of IL-17A and IL-17F. Gastroenterology 136, 257-267
43. Zhang, Z., Zheng, M., Bindas, J., Schwarzenberger, P. and Kolls, J.K. (2006) Critical role of IL-17 receptor signaling in acute TNBS-induced colitis. Inflamm. Bowel Dis. 12, 382-388
44. Shi, Y., Liu, X.F., Zhuang, Y., Zhang, J.Y., Liu, T., Yin, Z., Wu, C., Mao, X.H., Jia, K.R., Wang, F.J. et al. (2010) Helicobacter pylori-induced Th17 responses modulate Th1 cell responses, benefit bacterial growth, and contribute to pathology in mice. J. Immunol. 184, 5121-5129
45. Yen, D., Cheung, J., Scheerens, H., Poulet, F., McClanahan, T., McKenzie, B., Kleinschek, M.A., Owyang, A., Mattson, J., Blumenschein, W. et al. (2006) IL-23 is essential for T cell-mediated colitis and promotes inflammation via IL-17 and IL-6. J. Clin. Invest. 116, 1310-1316
46. Ivanov, I.I., Atarashi, K., Manel, N., Brodie, E.L., Shima, T., Karaoz, U., Wei, D., Goldfarb, K.C., Santee, C.A., Lynch, S.V. et al. (2009) Induction of intestinal Th17 cells by segmented filamentous bacteria. Cell 139, 485-498
47. Ishigame, H., Kakuta, S., Nagai, T., Kadoki, M., Nambu, A., Komiyama, Y., Fujikado, N., Tanahashi, Y., Akitsu, A., Kotaki, H. et al. (2009) Differential roles of interleukin-17A and -17F in host defense against mucoepithelial bacterial infection and allergic responses. Immunity 30, 108-119